Guardant Health Inc stock is traded at $147.54, with a volume of 123,204. It is down -2.74% in the last 24 hours and down -6.97% over the past month. Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Previous Close:
$151.70
Open:
$149.56
24h Volume:
123,204
Relative Volume:
0.04
Market Cap:
$19.96B
Revenue:
$1.08B
Net Income/Loss:
-$433.19M
P/E Ratio:
-
EPS:
-$3.40
Net Cash Flow:
-$225.09M
1W Performance:
-7.08%
1M Performance:
-6.97%
6M Performance:
+55.44%
1Y Performance:
+56.34%
1-Day Range:
$144.40$149.60
1-Week Range:
$144.40$163.39
52-Week Range:
$74.55$191.05
Guardant Health Inc Stock (GH) Company Profile
Name
Guardant Health IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
855-698-8887Address
3100 HANOVER STREET, PALO ALTO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS